Skip to content

Public FDA record

Z-2284-2023: Azurion 7 M20. X-ray Image guided Therapy System.

Recall record Z-2284-2023 for PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2284-2023
Company in FDA record
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
FDA classification date
Aug 2, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The bolts supporting the FlexMove Carriage may become loose and/or break, and cracks may appear in the suspension rail of the FlexMove Carriage.

Source facts

Action
Customers were mailed a recall notification dated 6/8/23 notifying them of this medical device correction. Customers are asked to retain the correction notice until all on-site are corrected, ensuring they are available to those who operate the device. If cracks in the FlexMove Carriage and/or abnormal noise during transversal movements of the C-Arc are observed, customers are to contact Philips so their field inspection may be prioritized. A diagram of crack locations on the FlexMove Carriage was provided for user reference. Customers are asked to return the provided Response Form no later than 30 days from receipt. Philips will contact customers to schedule a visit to inspect on-site systems and coordinate replacement of the affected bolts and/or FlexMove Carriage, as needed. Customers with any questions may contact Customer Care Solutions at 1-800-722-9377. Philips sent an updated notification to customers on 11/15/2024 with updated information regarding continued use and actions planned by Philips. Systems may be safely continuing to be sued for at least three (3) years after completing the inspectional activities described in the Correction and Removal Actions of the provided letter and Philips will contact customers to schedule a visit to install the permanent solution ensuring that it is implemented within 3 years after the initial inspectional activities or after installation. The permanent solution expected to be available by December 2024. Customers were also instructed to complete and return the Response Form.
Initiated
2023-06-12
Root cause
Component design/selection
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Georgia, Germany, Indonesia, Iran, Ireland, Italy, Japan, Jordan, Kenya, South Korea, Libya, Lithuania, Malaysia, Maldives, Morocco, Netherlands, New Caledonia, New Zealand, Norway, Oman, Panama, Philippines, Poland, Portugal, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom, Uruguay, & Vietnam.
Recall number
Z-2284-2023
Recall status
Open, Classified
CDRH record ID
201900
FDA classified
2023-08-02
Recall event number
92635

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗